Human Factors Testing for OTC Use of the Erchonia® LunulaLaser - Trial NCT05626270
Access comprehensive clinical trial information for NCT05626270 through Pure Global AI's free database. This phase not specified trial is sponsored by Erchonia Corporation and is currently Completed. The study focuses on Onychomycosis. Target enrollment is 15 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Erchonia Corporation
Timeline & Enrollment
N/A
Jun 04, 2021
Dec 23, 2022
Primary Outcome
Human Factors
Summary
Human factors validation testing to assess the intended user's ability to correctly, safely,
 and effectively set-up, activate and operate the LunulaLaser™ OTC, to administer a treatment
 to a suitably qualified client, and to understand the information contained in the Erchonia
 LunulaLaser™ OTC Installation and Proper Use Reference Guide and box labeling.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05626270
Device Trial